30 related articles for article (PubMed ID: 23464481)
1. A Review of Computational Methods for Cervical Cells Segmentation and Abnormality Classification.
Conceição T; Braga C; Rosado L; Vasconcelos MJM
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31618951
[TBL] [Abstract][Full Text] [Related]
2. Screening for cervical dysplasia and reproductive tract infections in Kerala, India: A multicentric study.
Tom JJ; Vaz C; Nisha C
J Family Med Prim Care; 2020 Aug; 9(8):4107-4111. PubMed ID: 33110817
[TBL] [Abstract][Full Text] [Related]
3. Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey.
Gultekin M; Karaca MZ; Kucukyildiz I; Dundar S; Keskinkilic B; Turkyilmaz M
Papillomavirus Res; 2019 Jun; 7():118-122. PubMed ID: 30878532
[TBL] [Abstract][Full Text] [Related]
4. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women.
Gultekin M; Zayifoglu Karaca M; Kucukyildiz I; Dundar S; Boztas G; Semra Turan H; Hacikamiloglu E; Murtuza K; Keskinkilic B; Sencan I
Int J Cancer; 2018 May; 142(9):1952-1958. PubMed ID: 29235108
[TBL] [Abstract][Full Text] [Related]
5. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
6. Cervical Cancer Screening in an Early Diagnosis and Screening Center in Mersin, Turkey.
Nayir T; Okyay RA; Nazlican E; Yesilyurt H; Akbaba M; Ilhan B; Kemik A
Asian Pac J Cancer Prev; 2015; 16(16):6909-12. PubMed ID: 26514466
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
8. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
9. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening in Turkey: a community-based experience after 60 years of pap smear usage.
Demirhindi H; Nazlican E; Akbaba M
Asian Pac J Cancer Prev; 2012; 13(12):6497-500. PubMed ID: 23464481
[TBL] [Abstract][Full Text] [Related]
11. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
William W; Ware A; Basaza-Ejiri AH; Obungoloch J
Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
[TBL] [Abstract][Full Text] [Related]
12. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
